Mavoglurant

N/A

Report date: 2024/05/07 15:21:03
NME

Base Information

Drug NameMavoglurant
Drug Alias Name玛沃谷兰马伏谷兰AFQ-056STP-7STP7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsSmoking CessationAlcohol DrinkingAlcohol Abstinence +[16
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[22
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesNovartis Pharma Ag
Active IndicationsAlcohol DrinkingAlcohol AbstinenceCocaine-Related Disorders +[5
Inactive IndicationsSmoking CessationFragile X SyndromeDyskinesia, Drug-Induced +[11

Other Information

ATC CodeN/A